Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept in Steroid Refractory Chronic Graft Versus Host Disease (cGVHD)
NCT01954979Phase 2Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Mar 2014
- Primary completion
- Jun 2023
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of abatacept in chronic graft-versus-host disease (cGVHD), sponsored by Beth Israel Deaconess Medical Center. Started Mar 2014; status: completed.
02
Drugs
abatacept
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on NCT01954979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01954979.